The DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.
New pharmacological strategies for augmenting extinction learning in anxiety disorders
Open accessAbstract
Despite advances in the treatment of fear-, anxiety- and trauma-related disorders, a considerable proportion of patients shows only partial long-term therapeutic benefit with existing treatments. A promising option in improving therapy is speeding up and boosting the effect of exposure-based therapy (EBT) by pharmacological interventions. Here, we will discuss select examples of novel concepts in augmenting fear extinction, the central mechanisms of EBT. Based on accumulating knowledge from animal and human studies concerning the neurocir-cuitries and neurobiological mechanisms underlying successful fear extinction, diverse potential pharmacological targets have been identified to optimize the efficacy of fear extinction. We focus here on selected examples of these targets and present translational evidence for strengthening fear inhibitory learning by using L-DOPA and D-cycloserine. Furthermore, the potential of HDAC inhibitors and microRNAs (e.g. miR-144) as epigenetic targets, as well as neuropeptide S as a model substance with combined acute anxiolytic and extinction-facilitating properties are discussed. The presented mechanisms represent promising novel strategies that may be useful in the future for augmenting the efficacy and improving the acceptance of EBT in the treatment of anxiety disorders, although further work remains to be done in characterising the underlying modes of action and safety aspects. © 2017 Spektrum Akademischer Verlag. All rights reserved.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This control of the ventromedial PFC [in humans; the homologous region in rodents is the infralimbic cortex (IL)] over the amygdala is important in modulating negative bias in anxiety (Carlisi & Robinson, 2018) or in fear extinction, a key fear-inhibitory mechanism underlying exposure-based therapy (EBT) [Section 8; (Heilbronner, Rodriguez-Romaguera, Quirk, Groenewegen, & Haber, 2016;Sartori &”
From Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders (2019) · cites this paper as Sartori & Singewald, 2017
In the citing paper
“At the moment it is not clear whether and how the existing rodent data concerning the pronounced anxiolytic effects of NPS can be translated into humans in particular due to lacking information on the exact distribution of NPS and its receptors system in the human brain and the lack of orally bioavailable and blood-brain barrier penetrating NPS receptor agonists (Sartori & Singewald, 2017).”
From Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders (2019) · cites this paper as Sartori & Singewald, 2017
Citations
Cites
The size and burden of mental disorders and other disorders of the brain in Europe 2010
Wittchen, H. U., Jacobi, F., Rehm, J., Gustavsson, A., Svensson, M., Jönsson, B., Olesen, J., Allgulander, C., Alonso, J., Faravelli, C., et al. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.07.018 · Cited by 3,754
Epidemiology of anxiety disorders in the 21st century
Bandelow, B., & Michaelis, S. (2015) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2015.17.3/bbandelow · Cited by 2,079 · cited 2×
“Up to 40% of the patients, who completed the therapy, do not show clinically relevant longterm treatment success (Bandelow and Michaelis, 2015).”
BackgroundNeuronal circuits for fear and anxiety
Tovote, P., Fadok, J. P., & Lüthi, A. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3945 · Cited by 1,786
Fear Extinction as a Model for Translational Neuroscience: Ten Years of Progress
Milad, M. R., & Quirk, G. J. (2012) · Annual Review of Psychology · doi:10.1146/annurev.psych.121208.131631 · Cited by 1,466
Scaling-up treatment of depression and anxiety: a global return on investment analysis
Chisholm, D., Sweeny, K., Sheehan, P., Rasmussen, B., Smit, F., Cuijpers, P., & Saxena, S. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30024-4 · Cited by 1,451 · cited 1×
“However, the treated patients’ labour participation and contribution to gross domestic product are about four times as much as costs for therapy (Chisholm et al., 2016).”
BackgroundSingewald, N., Schmuckermair, C., Whittle, N., Holmes, A., & Ressler, K. J. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.12.004 · Cited by 390 · cited 20×
“Trichostatin A, sodium butyrate, Entinostat (MS-275), Vorinostat (SAHA), valproate (VPA) and Cl-944 all exhibit fear extinction-promoting properties [for review see (Singewald et al., 2015)].”
BackgroundInfluentialSelf-citationJüngling, K., Seidenbecher, T., Sosulina, L., Lesting, J., Sangha, S., Clark, S. D., Okamura, N., Duangdao, D. M., Xu, Y.-L., Reinscheid, R. K., et al. (2008) · Neuron · doi:10.1016/j.neuron.2008.07.002 · Cited by 299 · cited 2×
“Animal studies revealed the specific pharmacological effects of NPS: anxiolytic and actiivty promoting and on top of that extinction memory augmenting [(Jungling et al., 2008; Slattery et al., 2015), for review see (Reinscheid et al., 2005)].”
BackgroundHefner, K., Whittle, N., Juhasz, J., Norcross, M., Karlsson, R.-M., Saksida, L. M., Bussey, T. J., Singewald, N., & Holmes, A. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4904-07.2008 · Cited by 248 · cited 2×
“Since the here presented selected examples DCS and HDAC-Is were not effective for severely deficient extinction when given before training (Hefner et al., 2008; Sartori et al., 2016), a combination of substances may be helpful with one given prior to the training, initiating extinction learning and allowing gradual fe…”
BackgroundSelf-citationDopamine and extinction: A convergence of theory with fear and reward circuitry
Abraham, A. D., Neve, K. A., & Lattal, K. M. (2014) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2013.11.007 · Cited by 208
The brain-specific microRNA miR-128b regulates the formation of fear-extinction memory
Lin, Q., Wei, W., Coelho, C. M., Li, X., Baker-Andresen, D., Dudley, K., Ratnu, V. S., Boskovic, Z., Kobor, M. S., Sun, Y. E., et al. (2011) · Nature Neuroscience · doi:10.1038/nn.2891 · Cited by 200 · cited 2×
“During extinction learning, regulatory mechanisms, e. g. via microRNAs miR128b (Lin et al., 2011) or miR144 [(Murphy et al., 2017); for review see (Singewald et al., 2015)] and also modifications of DNA and DNA-associated proteins, the histones, play a role.”
Background
Cited by
Sartori, S. B., & Singewald, N. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.107402 · Cited by 236
Self-citationSüß, S. T., Kremer, D., Olbricht, L. M., Herlitze, S., & Spoida, K. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02252-x · Cited by 14
Microglial pruning of extinction-ensemble synapses preserves fear memoryPreprint
Wang, Y., Cao, Y., Liu, T., Shi, T.-T., Zhao, Y., Jin, Z., Yang, X., Wang, S. Y., Ruan, J.-Z., Zhang, F., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.05.722833
Metadata
- Authors
- Sartori, S. B., & Singewald, N.
- Affiliations
- Universität Innsbruck (AT)
- Corresponding author
- Singewald, Nicolas
- Venue
- e-Neuroforum
- Publisher
- Walter de Gruyter GmbH
- Published
- 2017-11-23
- Volume
- 23
- Issue
- 4
- Pages
- A145-A156
- ISSN
- 0947-0875 (ISSN-L)
- 1868-856X
- OpenAlex
- W2768613025
- Cited by
- 3
- References
- 32
- Citations by year
- 2026: 1 · 2022: 1 · 2019: 1
- FWCI
- 0.16
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- e-Neuroforum (publishedVersion, cc-by-nc-nd)
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Memory and Neural Mechanisms
- Social Sciences › Psychology › Clinical Psychology › Posttraumatic Stress Disorder Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- fear extinction, anxiety disorders, exposure therapy, drug augmentation, L-DOPA, D-cycloserine, histone deacetylase inhibitors, microRNA-144, epigenetic targets, neuropeptide S, anxiolytic effects, treatment-resistant anxiety
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: New pharmacological strategies for augmenting extinction learning in anxiety disorders. https://app.cochat.ai/papers/10.1515/nf-2017-a011
- The paper
- Sartori, S. B., & Singewald, N. (2017). New pharmacological strategies for augmenting extinction learning in anxiety disorders. e-Neuroforum. https://doi.org/10.1515/nf-2017-a011
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.